Attitude of Health Personnel, Health Behavior, Human Papilloma Virus, Male, Papillomavirus Infections
Conditions
Keywords
Human Papillomavirus Vaccine, HPV, Patient Acceptance, Physician Comfort, Male Vaccination, HPV Associated Cancers
Brief summary
This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection. The research is focused on these questions: Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?
Detailed description
This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection. The research is focused on these questions: Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?
Interventions
OTHERSurvey
Clinical Faculty and community will be given a survey to define issues preventing HPV Vaccination
Sponsors
Louisiana State University Health Sciences Center Shreveport
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Community Participants Inclusion All visitors to the Pediatric or Internal Medicine University Health Shreveport Clinics willing to complete a survey Community Study Exclusion Those do not wish to participate in the study Those who English is not their first language Clinical Faculty, Resident, and Medical Student Study Inclusion All Louisiana State University Shreveport Health Clinical Faculty, Resident, and Medical Student Inclusion willing to to complete the online survey. Clinical Faculty, Resident, and Medical Student Study Exclusion Any LSU Health Shreveport Clinical Faculty, Resident, and Medical Student which declines to take the survey or do not attempt to complete it.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Barriers to HPV Vaccination | 60 days | What are the barriers which prevent community members and physicians, residents and medical students from ensuring that males age 9-26 are vaccinated with the HPV three-shot vaccination. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Knowledge pertaining to ease of Human Papillomavirus transmission. | 60 days | Do community members and physicians understand the ease of HPV transmission? |
| Knowledge of Associated HPV diseases | 60 days | Do community member and physicians know the associated HPV diseases? |
| Knowledge of age in which males should be vaccinated against HPV. | 60 days | Do community member and physicians know the age in which males should be vaccinated against HPV? |
Countries
United States
Outcome results
None listed